BRIEF-Abiomed Impella CP receives expanded FDA approval for high-risk percutaneous coronary intervention (PCI) procedures
December 07, 2016 at 07:36 AM EST
* Has expanded FDA pre-market approval for impella heart pump use in PCI to include impella cp heart pump
